Market Cap

Eurofins-Cerep Market Capitalization:

€112.0 Million

EUR as of July 1, 2024

US$120.3 Million

business Eurofins-Cerep Company Profile

Eurofins-Cerep Main Stock Listing

Euronext: ALECR

Market Capitalization History of Eurofins-Cerep

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Eurofins-Cerep market cap

Date Market Cap YoY Change
Jan. 1, 2024 €126.1 M 13.39%
Jan. 1, 2023 €111.2 M 26.71%
Jan. 1, 2022 €87.8 M 32.82%
Jan. 1, 2021 €66.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Eurofins-Cerep Categories

France languages Healthcare languages Drug Manufacturers—General
France Healthcare France Drug Manufacturers—General

Stocks & Indices

Eurofins-Cerep has the following listings and related stock indices.


Stock: Euronext: ALECR

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.